6.589

1.24% -0.061

Ginkgo Bioworks Holdings Inc (DNA)

Overview News Price History Option Chain Why DNA Down? Discussions Forecast

Ginkgo Bioworks Holdings Inc stock is traded at $6.589, with a volume of 332.53K. It is down -1.24% in the last 24 hours and down -51.53% over the past month. Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.

Previous Close:

$6.65

Open:

$6.77

24h Volume:

332.53K

Relative Volume:

0.20

Market Cap:

$380.12M

Revenue:

$217.11M

Net Income/Loss:

$-651.19M

P/E Ratio:

-0.5072

EPS:

-12.99

Net Cash Flow:

$-387.26M

1W Performance:

-15.91%

1M Performance:

-51.53%

6M Performance:

+3.92%

1Y Performance:

-85.97%

1-Day Range:

$6.53

$6.90

1-Week Range:

$6.53

$7.78

52-Week Range:

$5.26

$48.00

Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile

Name

Ginkgo Bioworks Holdings Inc

Sector

Healthcare (1172)

Industry

Biotechnology (680)

Phone

(877) 442-5362

Address

27 DRYDOCK AVENUE, BOSTON

Employee

834

Twitter

Next Earnings Date

2024-08-08

Latest SEC Filings

DNA's Discussions on Twitter

Compare DNA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DNA Ginkgo Bioworks Holdings Inc	6.59	380.12M	217.11M	-651.19M	-387.26M	-12.99
VRTX Vertex Pharmaceuticals Inc	502.81	130.96B	11.02B	-535.60M	-978.00M	-2.20
REGN Regeneron Pharmaceuticals Inc	684.98	75.53B	14.20B	4.41B	3.54B	38.28
ARGX Argen X Se Adr	578.98	35.07B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	242.67	31.72B	2.25B	-278.16M	-42.59M	-2.17
ONC Beigene Ltd Adr	250.16	26.76B	3.32B	-860.46M	-1.04B	-8.32

Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
May-15-24	Downgrade	BTIG Research	Neutral → Sell
May-10-24	Downgrade	William Blair	Mkt Perform → Underperform
Nov-14-23	Downgrade	Raymond James	Outperform → Mkt Perform
Nov-09-23	Downgrade	BTIG Research	Buy → Neutral
Jun-02-23	Downgrade	Goldman	Neutral → Sell
May-11-23	Downgrade	William Blair	Outperform → Mkt Perform
Nov-29-22	Initiated	Berenberg	Buy
Oct-04-22	Initiated	Morgan Stanley	Equal-Weight
May-18-22	Downgrade	BofA Securities	Neutral → Underperform
Mar-02-22	Resumed	Cowen	Outperform
Feb-23-22	Initiated	Goldman	Neutral
Feb-01-22	Initiated	BofA Securities	Neutral
Jan-28-22	Initiated	BofA Securities	Buy
Jan-07-22	Initiated	BTIG Research	Buy
Nov-29-21	Initiated	Jefferies	Buy
Oct-13-21	Initiated	Raymond James	Outperform
Oct-12-21	Initiated	William Blair	Outperform
Sep-20-21	Initiated	HSBC Securities	Buy

View All

Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News

04:05 AM

SBI Securities Co. Ltd. Acquires Shares of 2,905 Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World

04:05 AM

Mar 08, 2025

Ginkgo Bioworks (DNA) Upgraded to Buy: Here's Why - MSN

Mar 08, 2025

Mar 07, 2025

Ginkgo Bioworks Partners with HaDEA in Up to €24 Million Consort - GuruFocus.com

Mar 07, 2025

Ginkgo Bioworks (DNA) Insider Trading Activity 2025 - MarketBeat

Mar 07, 2025

Mar 06, 2025

Ginkgo Bioworks CFO sells shares worth $6,102 - Investing.com India

Mar 06, 2025

Ginkgo Bioworks CFO sells shares worth $6,102 By Investing.com - Investing.com South Africa

Mar 06, 2025

Ginkgo Bioworks executive sells shares for over $3k - Investing.com

Mar 06, 2025

Y Intercept Hong Kong Ltd Purchases New Position in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) - Defense World

Mar 06, 2025

Mar 05, 2025

(DNA) Pivots Trading Plans and Risk Controls - Stock Traders Daily

Mar 05, 2025

Mar 04, 2025

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Ginkgo Bioworks Holdings, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of January 18, 2022DNA - ACCESS Newswire

Mar 04, 2025

Mar 03, 2025

Global Microbial Fermentation Technology Market to Increase at a Steady Growth Rate of ~5% by 2032 | DelveInsight - GlobeNewswire Inc.

Mar 03, 2025

Mar 02, 2025

5 "Best" Publicly Traded Synthetic Biology Companies - Securities.io

Mar 02, 2025

Mar 01, 2025

These Analysts Think Ginkgo Bioworks Holdings, Inc.'s (NYSE:DNA) Sales Are Under Threat - Simply Wall St

Mar 01, 2025

Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday - MarketBeat

Mar 01, 2025

Ginkgo Bioworks (NYSE:DNA) Shares Gap DownHere's What Happened - MarketBeat

Mar 01, 2025

Ginkgo Bioworks (NYSE:DNA) Posts Quarterly Earnings Results, Misses Expectations By $0.37 EPS - MarketBeat

Mar 01, 2025

Feb 28, 2025

Ginkgo Bioworks (NYSE:DNA) Posts Earnings Results - MarketBeat

Feb 28, 2025

DNA; SRNG Upcoming Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Ginkgo Bioworks Holdings Inc. (f/k/a Soaring Eagle Acquisition Corp.) Investors of Class Action and Deadline: January 18, 2022 - ACCESS Newswire

Feb 28, 2025

Feb 27, 2025

Ginkgo Bioworks Earnings Call: Mixed Sentiments and Strategic Moves - TipRanks

Feb 27, 2025

Ginkgo Bioworks Shrinks Office and Lab Footprint in Boston, Cambridge - Connect CRE

Feb 27, 2025

Ginkgo Bioworks: Revenue Struggles Continue - Seeking Alpha

Feb 27, 2025

2025 Is Make Or Break For Ginkgo Bioworks (NYSE:DNA) - Seeking Alpha

Feb 27, 2025

Ginkgo Bioworks Holdings Full Year 2024 Earnings: EPS Misses Expectations - Yahoo Finance

Feb 27, 2025

Feb 26, 2025

Ginkgo Bioworks: Key Takeaways from Q4 and Full-Year 2024 Earnings Report - HPBL

Feb 26, 2025

Cautious Outlook on Ginkgo Bioworks: Sell Rating Amid Financial and Strategic Concerns - TipRanks

Feb 26, 2025

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 26, 2025